GLENMARK PHARMACEUTICALS
Back to Cashflow Statement
|
GLENMARK PHARMACEUTICALS Last 5 Year Net Cash Inflow / Outflow History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Net Cash Inflow / Outflow | ₹-547 Cr | ₹-38 Cr | ₹389 Cr | ₹19 Cr | ₹255 Cr |
What is the latest Net Cash Inflow / Outflow ratio of GLENMARK PHARMACEUTICALS ?
| Year | Net Cash Inflow / Outflow |
|---|---|
| Mar2026 | ₹-547 Cr |
| Mar2025 | ₹-38 Cr |
| Mar2024 | ₹389 Cr |
| Mar2023 | ₹19 Cr |
| Mar2022 | ₹255 Cr |
How is Net Cash Inflow / Outflow of GLENMARK PHARMACEUTICALS Trending?
| Years | Net Cash Inflow / Outflow | % Change | |
|---|---|---|---|
| Mar2026 | ₹-547 Cr | Negative | |
| Mar2025 | ₹-38 Cr | Negative | |
| Mar2024 | ₹389 Cr | 1,902.17 | |
| Mar2023 | ₹19 Cr | -92.37 | |
| Mar2022 | ₹255 Cr | - | |
Compare Net Cash Inflow / Outflow of peers of GLENMARK PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| GLENMARK PHARMACEUTICALS | ₹74,924.1 Cr | -2.3% | 17.5% | 42.3% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹449,228.0 Cr | -1.4% | 6.3% | 7.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹293,874.0 Cr | -1.8% | 20.6% | 70.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,413.0 Cr | -1.9% | 2.4% | 22.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹116,604.0 Cr | 0.8% | 12.6% | 12.3% | Stock Analytics | |
| CIPLA | ₹114,720.0 Cr | -2.4% | 4.4% | -8.3% | Stock Analytics | |
GLENMARK PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| GLENMARK PHARMACEUTICALS | -2.3% |
17.5% |
42.3% |
| SENSEX | 0.2% |
9.8% |
-2.9% |
You may also like the below Video Courses